As of 2024-12-12, the Intrinsic Value of Amneal Pharmaceuticals Inc (AMRX) is
2.77 USD. This Amneal valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 8.10 USD, the upside of Amneal Pharmaceuticals Inc is
-65.90%.
The range of the Intrinsic Value is (2.10) - 36.39 USD
Amneal Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(2.10) - 36.39 |
2.77 |
-65.9% |
| DCF (Growth 10y) |
1.59 - 59.56 |
8.97 |
10.8% |
| DCF (EBITDA 5y) |
7.11 - 11.30 |
9.75 |
20.3% |
| DCF (EBITDA 10y) |
10.26 - 17.82 |
14.37 |
77.5% |
| Fair Value |
-2.38 - -2.38 |
-2.38 |
-129.44% |
| P/E |
0.62 - 0.80 |
0.68 |
-91.6% |
| EV/EBITDA |
2.80 - 19.24 |
10.32 |
27.4% |
| EPV |
0.52 - 6.72 |
3.62 |
-55.3% |
| DDM - Stable |
0.33 - 1.13 |
0.73 |
-91.0% |
| DDM - Multi |
0.51 - 1.41 |
0.75 |
-90.7% |
Amneal Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,507.27 |
| Beta |
0.87 |
| Outstanding shares (mil) |
309.54 |
| Enterprise Value (mil) |
2,507.27 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.87% |
| Cost of Debt |
9.16% |
| WACC |
8.08% |